Cargando…

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal tissues. The α-emitting radionuclide bismuth-213 ((...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahenkorah, Stephen, Cassells, Irwin, Deroose, Christophe M., Cardinaels, Thomas, Burgoyne, Andrew R., Bormans, Guy, Ooms, Maarten, Cleeren, Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143329/ https://www.ncbi.nlm.nih.gov/pubmed/33919391 http://dx.doi.org/10.3390/pharmaceutics13050599

Ejemplares similares

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
por: Cassells, Irwin, et al.
Publicado: (2021)

3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022)

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021)

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
por: Van de Voorde, Michiel, et al.
Publicado: (2021)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

Gamma radiation effects on AG MP-50 cation exchange resin and sulfonated activated carbon for bismuth-213 separation
por: Zhu, Hongshan, et al.
Publicado: (2023)

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018)

Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617
por: Kratochwil, Clemens, et al.
Publicado: (2017)

Supply and Clinical Application of Actinium-225 and Bismuth-213
por: Morgenstern, Alfred, et al.
Publicado: (2020)

Gamma counting protocols for the accurate quantification of (225)Ac and (213)Bi without the need for a secular equilibrium between parent and gamma-emitting daughter
por: Castillo Seoane, Dayana, et al.
Publicado: (2022)

Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe(3)O(4)@Al(OH)(3) nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution
por: Belderbos, Sarah, et al.
Publicado: (2020)

Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging
por: González-Gómez, Manuel Antonio, et al.
Publicado: (2019)

A Radionuclide Generator of High-Purity Bi-213 for Instant Labeling
por: Ermolaev, Stanislav, et al.
Publicado: (2021)

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy
por: Chan, Ho Sze, et al.
Publicado: (2017)

(213)Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
por: Sathekge, Mike, et al.
Publicado: (2017)

Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report
por: Haemels, Maarten, et al.
Publicado: (2020)

Manifestation of the Berry phase in the atomic nucleus $^{213}$Pb
por: Valiente-Dobón, J.J., et al.
Publicado: (2020)

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics
por: Murce, Erika, et al.
Publicado: (2023)

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
por: Allen, Kevin J. H., et al.
Publicado: (2019)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

Micro-flow photosynthesis of new dienophiles for inverse-electron-demand Diels–Alder reactions. Potential applications for pretargeted in vivo PET imaging
por: Billaud, Emilie M. F., et al.
Publicado: (2017)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

(213)Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
por: Kratochwil, C., et al.
Publicado: (2014)

Parity violation in bismuth atoms and weak interaction neutral currents
por: Barkov, L M, et al.
Publicado: (1980)

Lead-Bismuth Eutectic: Atomic and Micro-Scale Melt Evolution
por: Montanari, Roberto, et al.
Publicado: (2019)

Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients
por: Benedetti, Edoardo, et al.
Publicado: (2023)

Single-atom nanozymes: From bench to bedside
por: Jin, Chanyuan, et al.
Publicado: (2022)

Strong magnetoelectric coupling at an atomic nonmagnetic electromagnetic probe in bismuth ferrite
por: Schell, Juliana, et al.
Publicado: (2022)

In situ study on atomic mechanism of melting and freezing of single bismuth nanoparticles
por: Li, Yingxuan, et al.
Publicado: (2017)

Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
por: Bridoux, Jessica, et al.
Publicado: (2020)

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
por: Fichou, Nolwenn, et al.
Publicado: (2015)

Study of the neutron deficient lead and bismuth isotopes by simultaneous atomic and nuclear spectroscopy
por: Franchoo, S, et al.
Publicado: (2004)

Optical pumping and readout of bismuth hyperfine states in silicon for atomic clock applications
por: Saeedi, K., et al.
Publicado: (2015)

Colloid driven low supersaturation crystallization for atomically thin Bismuth halide perovskite
por: Li, Lutao, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

Al(18)F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging
por: Cleeren, Frederik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4om4uv9ub85pbc8vll7o1nifns